It's really a drug designed by Hoffmann-La Roche which functions for a powerful and selective destructive allosteric modulator for group II in the metabotropic glutamate receptors (mGluR2/three), being equipotent at mGluR2 and mGluR3 but devoid of exercise at other mGluR subtypes.Serious pores and skin reactions: VOQUEZNA may cause rare, but severe